La Queue-en-Brie, France

Michel Evers


 

Average Co-Inventor Count = 6.4

ph-index = 10

Forward Citations = 250(Granted Patents)


Location History:

  • Liege, BE (1992 - 1995)
  • La Queue En Brie, FR (1999 - 2011)
  • Paris, FR (2013)

Company Filing History:


Years Active: 1992-2013

Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: Michel Evers - Innovator in Medicinal Chemistry

Introduction

Michel Evers, a talented inventor based in La Queue en Brie, France, has made significant contributions to the field of medicinal chemistry. With an impressive portfolio of 23 patents, his work primarily revolves around the development of novel therapeutic compounds.

Latest Patents

Some of his latest patents include the following innovative derivatives:

1. 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof. This invention pertains to the derivatives of these compounds and their preparation and therapeutic potential.

2. Pyrazolyl derivatives, preparation process, and intermediates of this process as medicinal products and pharmaceutical compositions containing them. This patent details novel derivatives of formula (I) with specific structural features and potential applications in medicine.

Career Highlights

Michel Evers has distinguished himself in the pharmaceutical industry, having worked with notable companies such as Aventis Pharma and Rhône-Poulenc Rorer. His expertise in medicinal chemistry has allowed him to develop groundbreaking compounds that have significant therapeutic implications.

Collaborations

Throughout his career, Evers has collaborated with esteemed colleagues, including Serge Mignani and Jean-Christophe Carry. These partnerships have contributed to the success of his research endeavors and the advancement of innovative pharmaceuticals.

Conclusion

Michel Evers stands out as a leading figure in the field of medicinal chemistry with his prolific patent portfolio and impactful collaborations. His inventions continue to play a critical role in the development of new therapeutic agents, underscoring the importance of innovation in enhancing healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…